The Value of Urinary Fibrin/Fibrinogen Degradation Products as Tumor Markers in Urothelial Carcinoma
- 1 July 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 132 (1) , 21-23
- https://doi.org/10.1016/s0022-5347(17)49445-6
Abstract
Urinary fibrin/fibrinogen degradation products as biological tumor markers in urothelial carcinoma were studied and compared to urinary cytology. In 93% of the patients with urothelial carcinoma urinary fibrin/fibrinogen degradation product levels were elevated significantly. There was excellent correlation when the urinary cytology and urinary fibrin/fibrinogen degradation product results were compared together to cystoscopic findings.This publication has 15 references indexed in Scilit:
- Rationale for Intensive Intravesical Chemotherapy for Superficial Bladder CancerJournal of Urology, 1980
- Serial Multiple-Site Biopsies in Patients with Bladder CancerJournal of Urology, 1978
- Evaluation of Biological Markers in Bladder CancerJournal of Urology, 1975
- Susceptibility of urothelium to neoplastic cellular implantationUrology, 1975
- Lymphocytes and Bladder CancerJournal of Urology, 1974
- Serum and Urinary Fibrin/Fibrinogen Degradation Products in GlomerulonephritisBMJ, 1971
- Carcinoma of the bladder treated by suprapubic radium implantsEuropean Journal of Cancer (1965), 1969
- Recurrence of Bladder Tumors by Surgical ImplantationJournal of Urology, 1956
- Clinical Implications of Transplantability of Induced Bladder Tumors to Intact Transitional Epithelium in DogsJournal of Urology, 1956
- Bladder Tumor Recurrence in the Urethra: A WarningJournal of Urology, 1953